Published in J Am Coll Cardiol on December 20, 2005
Predictors of left ventricular remodelling and failure in right ventricular pacing in the young. Eur Heart J (2009) 1.58
Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm (2009) 1.58
Measures of dyssynchrony in the left ventricle of healthy children and young patients with dilated cardiomyopathy. J Am Soc Echocardiogr (2012) 1.08
Cardiac resynchronization therapy in pediatric congenital heart disease: insights from noninvasive electrocardiographic imaging. Heart Rhythm (2009) 1.07
Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease. Heart Fail Rev (2011) 1.04
Cardiac resynchronization therapy in children. Curr Cardiol Rev (2009) 0.94
The right ventricle: biologic insights and response to disease: updated. Curr Cardiol Rev (2013) 0.93
Cardiac resynchronization therapy for patients with congenital heart disease: technical challenges. J Interv Card Electrophysiol (2012) 0.91
Right ventricular mechanics using a novel comprehensive three-view echocardiographic strain analysis in a normal population. J Am Soc Echocardiogr (2014) 0.90
Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography. Heart Fail Rev (2010) 0.89
Presence of mechanical dyssynchrony in Duchenne muscular dystrophy. J Cardiovasc Magn Reson (2011) 0.87
Chronic left ventricular pacing preserves left ventricular function in children. Pediatr Cardiol (2008) 0.86
Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart (2009) 0.84
The right ventricle: biologic insights and response to disease. Curr Cardiol Rev (2009) 0.84
What is new in pediatric cardiac imaging? Eur J Pediatr (2007) 0.82
Pacing device therapy in infants and children: a review. J Artif Organs (2012) 0.81
Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up. Front Pediatr (2013) 0.80
Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator. Korean J Thorac Cardiovasc Surg (2015) 0.80
Evaluation of right ventricular contraction by myocardial strain in children using a two-dimensional tissue tracking method. Pediatr Cardiol (2007) 0.79
Clinical practice: heart failure in children. Part II: current maintenance therapy and new therapeutic approaches. Eur J Pediatr (2010) 0.79
Biventricular pacing in an infant with noncompaction of the ventricular myocardium, congenital AV block, and prolonged QT interval. J Interv Card Electrophysiol (2009) 0.79
Fontan "Ten Commandments" revisited and revised. Pediatr Cardiol (2010) 0.78
The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances. J Clin Exp Cardiolog (2012) 0.77
Device therapy in children with and without congenital heart disease. Herzschrittmacherther Elektrophysiol (2014) 0.76
Right ventricular failure in congenital heart disease. Korean J Pediatr (2013) 0.76
Effective cardiac resynchronization therapy for an adolescent patient with dilated cardiomyopathy seven years after mitral valve replacement and septal anterior ventricular exclusion. J Cardiothorac Surg (2010) 0.75
Experts' recommendations for the management of cardiogenic shock in children. Ann Intensive Care (2016) 0.75
An approach to overcoming specific difficulties with cardiac resynchronization therapy in children. Indian Pacing Electrophysiol J (2008) 0.75
Pacing and Defibrillators in Complex Congenital Heart Disease. Arrhythm Electrophysiol Rev (2016) 0.75
Cardiac resynchronization therapy for left ventricular dysfunction induced by chronic right ventricular pacing in a child. J Korean Med Sci (2010) 0.75
Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension. Oncotarget (2016) 0.75
Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation. Circulation (2014) 0.75
Managing Heart Failure in Transposition of the Great Arteries. Ochsner J (2015) 0.75
Cardiac pacing and defibrillation in children and young adults. Indian Pacing Electrophysiol J (2013) 0.75
Resynchronization therapy in an adolescent with pacemaker-related ventricular dysfunction. Ann Pediatr Cardiol (2012) 0.75
Does biventricular pacing improve hemodynamics in children undergoing routine congenital heart surgery? Pediatr Cardiol (2010) 0.75
Improvement of cardiac geometry and function after cardiac resynchronization therapy for relapsed deterioration of pediatric dilated cardiomyopathy due to a noncompacted left ventricle and cardiac dyssynchrony. Pediatr Cardiol (2011) 0.75
Deleterious effect of unintentional pacing from the middle cardiac vein in a patient with congenitally corrected transposition of the great arteries and ventricular septal defect. The beneficial effect of cardiac resynchronization therapy after heart surgery. J Interv Card Electrophysiol (2008) 0.75
A hybrid form of cardiac resynchronisation therapy in patients with failing systemic right ventricles. J Interv Card Electrophysiol (2008) 0.75
Cardiac resynchronization therapy in congenital heart disease. Herzschrittmacherther Elektrophysiol (2016) 0.75
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med (2007) 6.22
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet (2008) 5.07
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol (2009) 4.38
Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell (2008) 4.06
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A (2003) 3.46
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr (2008) 3.44
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis (2009) 3.28
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood (2003) 2.76
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation (2007) 2.76
Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children. J Am Coll Cardiol (2011) 2.65
Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation (2008) 2.52
A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm (2008) 2.47
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood (2004) 2.42
Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation (2009) 2.26
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood (2009) 2.15
First appropriate use of automated external defibrillator in an infant. Resuscitation (2005) 2.14
Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke (2005) 2.03
Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J (2004) 2.01
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. J Hepatol (2009) 1.98
Electrophysiologic considerations in congenital heart disease and their relationship to heart failure. Can J Cardiol (2013) 1.98
Brugada phenocopy with a flecainide overdose: a pharmacological dose effect? J Cardiovasc Electrophysiol (2013) 1.98
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood (2005) 1.96
A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol (2006) 1.95
Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol (2004) 1.81
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci (2005) 1.75
Inaccuracy of Wolff-Parkinson-white accessory pathway localization algorithms in children and patients with congenital heart defects. J Cardiovasc Electrophysiol (2006) 1.75
GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta (2002) 1.74
Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol (2006) 1.73
Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. Mol Cell (2003) 1.72
Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm (2008) 1.71
Targeting oncogenic Ras signaling in hematologic malignancies. Blood (2012) 1.67
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.65
Long QT syndrome in children in the era of implantable defibrillators. J Am Coll Cardiol (2007) 1.63
MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene (2002) 1.62
C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int (2008) 1.61
Improved localization of right-sided accessory pathways with microcatheter-assisted right coronary artery mapping in children. J Cardiovasc Electrophysiol (2004) 1.60
Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol (2010) 1.59
MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood (2008) 1.59
Implications of anesthesia in children with long QT syndrome. Anesth Analg (2011) 1.59
Adverse effects of Wolff-Parkinson-White syndrome with right septal or posteroseptal accessory pathways on cardiac function. Europace (2008) 1.59
Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm (2004) 1.59
Predictors of left ventricular remodelling and failure in right ventricular pacing in the young. Eur Heart J (2009) 1.58
Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm (2006) 1.57
Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation (2002) 1.57
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol (2015) 1.56
Endocardial pacemaker implantation in infants weighing < or = 10 kilograms. Pacing Clin Electrophysiol (2004) 1.56
Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry. Circ Arrhythm Electrophysiol (2012) 1.56
Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm (2005) 1.55
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation (2010) 1.55
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med (2009) 1.53
Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing Clin Electrophysiol (2006) 1.53
Focus on myeloproliferative diseases and myelodysplastic syndromes. Cancer Cell (2004) 1.52
Clinical decisions. Cardiac screening before participation in sports. N Engl J Med (2013) 1.51
Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm (2009) 1.50
Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm (2009) 1.48
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006. J Hepatol (2007) 1.48
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace (2013) 1.47
Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol (2008) 1.47
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol (2011) 1.47
Characterizing dual atrioventricular nodal physiology in pediatric patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (2006) 1.46
Giant cell myocarditis mimicking idiopathic fascicular ventricular tachycardia. J Heart Lung Transplant (2008) 1.46
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study. Circulation (2013) 1.46
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum (2008) 1.46
What is the feasibility of imaging coronary arteries during routine echocardiograms in children? J Am Soc Echocardiogr (2002) 1.45
Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation (2009) 1.45
Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol (2011) 1.45
Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population. J Cardiovasc Electrophysiol (2008) 1.45
Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health (2005) 1.45
Time and temperature profile of catheter cryoablation of right septal and free wall accessory pathways in children. J Cardiovasc Electrophysiol (2007) 1.44
Invasive measurements of atrioventricular conduction parameters prior to and following ventricular septal defect closure with the amplatzer device. J Invasive Cardiol (2008) 1.44
Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children. J Pediatr Gastroenterol Nutr (2009) 1.44
Atrioventricular nodal reentrant tachycardia in children: effect of slow pathway ablation on fast pathway function. J Cardiovasc Electrophysiol (2002) 1.43
Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol (2013) 1.43
Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter-defibrillators. Heart Rhythm (2013) 1.43
Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation (2010) 1.42
Arrhythmias in adult patients with congenital heart disease. Circulation (2007) 1.42
Short- and long-term outcomes in children undergoing radiofrequency catheter ablation before their second birthday. Can J Cardiol (2011) 1.41
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee. Heart Rhythm (2013) 1.41
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum (2012) 1.40